Legend Biotech (LEGN) EBT Margin (2019 - 2025)
Legend Biotech (LEGN) posted EBT Margin of 6.4% for Q4 2025, up 55.4% quarter-over-quarter from 14.35% in Q3 2025, and down 2811.0% year-on-year from 0.24% in Q4 2024.
Legend Biotech (LEGN) EBT Margin (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has reported EBT Margin for 7 consecutive years, with 6.4% the latest figure, recorded in Q4 2025.
- EBT Margin for Q4 2025 came in at 6.4%, down 2811.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 27.47% (down 226.0% YoY), and the FY2025 annual result was 27.47%, down 226.0% from the prior year.
- EBT Margin was 6.4% for Q4 2025 at Legend Biotech, up from 14.35% in the prior quarter.
- Over five years, EBT Margin peaked at 1956.06% in Q3 2022 and troughed at 1612.82% in Q2 2022.
- Average EBT Margin over 5 years is 101.76%, with a median of 57.22% recorded in 2024.
- The widest YoY moves for EBT Margin: up 269502 bps in 2022, down 246577 bps in 2022.
- Over 5 years, EBT Margin stood at 1044.23% in 2021, then soared by 53 bps to 491.16% in 2022, then jumped by 100 bps to 0.18% in 2023, then jumped by 11854 bps to 21.72% in 2024, then sank by 129 bps to 6.4% in 2025.
- Per Business Quant data, the three most recent EBT Margin figures were 6.4% in Q4 2025, 14.35% in Q3 2025, and 48.93% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 8.26% |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 17.13% |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 41.95% |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -6.78% |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 23.05% |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 33.74% |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 18.99% |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Legend Biotech | 11.04 Bn | 10.14 Bn | 242.10 Mn | -6.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.43% |
| Sep 30, 2025 | -14.35% |
| Jun 30, 2025 | -48.93% |
| Mar 31, 2025 | -50.82% |
| Dec 31, 2024 | 21.77% |
| Sep 30, 2024 | -75.46% |
| Jun 30, 2024 | -9.63% |
| Mar 31, 2024 | -63.61% |
| Dec 31, 2023 | -0.18% |
| Sep 30, 2023 | -712.53% |
| Jun 30, 2023 | 576.55% |
| Mar 31, 2023 | -308.16% |
| Dec 31, 2022 | -491.16% |
| Sep 30, 2022 | 1,956.06% |
| Jun 30, 2022 | -1,612.82% |
| Mar 31, 2022 | -64.20% |
| Dec 31, 2021 | -226.53% |
| Sep 30, 2021 | -738.96% |
| Jun 30, 2021 | -852.01% |
| Mar 31, 2021 | -0.69% |